Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Ramaa

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Medicinal Chemistry|July 30, 2010
Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivativesVijay Patil, Kalpana Tilekar, Sonali Mehendale-Munj, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2020
Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with ImatinibHardik Joshi, Vijay Patil, Kalpana Tilekar, et al.
Bioorganic Chemistry|July 9, 2016
5-Benzylidene-2,4-thiazolidenedione derivatives: Design, synthesis and evaluation as inhibitors of angiogenesis targeting VEGR-2Umesh Bhanushali, Saranya Rajendran, Keerthana Sarma, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 23, 2020
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancerKalpana Tilekar, Neha Upadhyay, Cristina V Iancu, et al.
Journal of Cancer Research and Therapeutics|October 15, 2014
A novel series of di-fluorinated propanedione derivatives synergistically augment paclitaxel mediated caspase 3 activation in ovarian cancer cellsJyothi Nagraj, Subhoshree Chatterjee, Tanushree Pal, et al.
Bioorganic Chemistry|January 6, 2020
Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell linesKalpana Tilekar, Neha Upadhyay, Niklas Jänsch, et al.
Future Medicinal Chemistry|September 28, 2021
Development and investigation of thiazolidinedione and pyrazoline compounds as antiangiogenic weapons targeting VEGFR-2Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Bioorganic Chemistry|September 21, 2021
Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesisNeha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
European Journal of Medicinal Chemistry|July 8, 2020
Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potentialKalpana Tilekar, Neha Upadhyay, Jessica D Hess, et al.
Bioorganic Chemistry|May 24, 2020
Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluationNeha Upadhyay, Kalpana Tilekar, Niklas Jänsch, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Medicinal Chemistry|July 30, 2010
Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivativesVijay Patil, Kalpana Tilekar, Sonali Mehendale-Munj, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2020
Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with ImatinibHardik Joshi, Vijay Patil, Kalpana Tilekar, et al.
Bioorganic Chemistry|July 9, 2016
5-Benzylidene-2,4-thiazolidenedione derivatives: Design, synthesis and evaluation as inhibitors of angiogenesis targeting VEGR-2Umesh Bhanushali, Saranya Rajendran, Keerthana Sarma, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 23, 2020
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancerKalpana Tilekar, Neha Upadhyay, Cristina V Iancu, et al.
Journal of Cancer Research and Therapeutics|October 15, 2014
A novel series of di-fluorinated propanedione derivatives synergistically augment paclitaxel mediated caspase 3 activation in ovarian cancer cellsJyothi Nagraj, Subhoshree Chatterjee, Tanushree Pal, et al.
Bioorganic Chemistry|January 6, 2020
Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell linesKalpana Tilekar, Neha Upadhyay, Niklas Jänsch, et al.
Future Medicinal Chemistry|September 28, 2021
Development and investigation of thiazolidinedione and pyrazoline compounds as antiangiogenic weapons targeting VEGFR-2Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Bioorganic Chemistry|September 21, 2021
Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesisNeha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
European Journal of Medicinal Chemistry|July 8, 2020
Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potentialKalpana Tilekar, Neha Upadhyay, Jessica D Hess, et al.
Bioorganic Chemistry|May 24, 2020
Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluationNeha Upadhyay, Kalpana Tilekar, Niklas Jänsch, et al.
Pageof 3